|
ZNF720 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.7173000000057E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.863600E-03 |
| Normal-vs-Stage2 |
1.339440E-01 |
| Normal-vs-Stage3 |
4.00540000000671E-06 |
| Normal-vs-Stage4 |
1.4143000000022E-06 |
| Stage1-vs-Stage2 |
9.332400E-01 |
| Stage1-vs-Stage3 |
1.571590E-02 |
| Stage1-vs-Stage4 |
8.282500E-03 |
| Stage2-vs-Stage3 |
1.825220E-01 |
| Stage2-vs-Stage4 |
1.437370E-01 |
| Stage3-vs-Stage4 |
8.034200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.94355999999507E-05 |
| Normal-vs-AfricanAmerican |
9.095600E-02 |
| Normal-vs-Asian |
7.483200E-01 |
| Caucasian-vs-AfricanAmerican |
5.066600E-01 |
| Caucasian-vs-Asian |
3.025200E-01 |
| AfricanAmerican-vs-Asian |
6.095600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.74929999999996E-05 |
| Normal-vs-Female |
7.019800E-04 |
| Male-vs-Female |
5.103400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.267700E-02 |
| Normal-vs-Age(41-60Yrs) |
7.856900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.88700000003372E-06 |
| Normal-vs-Age(81-100Yrs) |
4.45840000000697E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.793400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.337200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.699360E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.004300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.498300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.405800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.697800E-01 |
| Normal-vs-Grade 2 |
4.581500E-03 |
| Normal-vs-Grade 3 |
1.81593999999397E-05 |
| Normal-vs-Grade 4 |
1.88270000001101E-06 |
| Grade 1-vs-Grade 2 |
3.250800E-01 |
| Grade 1-vs-Grade 3 |
8.023900E-02 |
| Grade 1-vs-Grade 4 |
1.526460E-02 |
| Grade 2-vs-Grade 3 |
9.428100E-02 |
| Grade 2-vs-Grade 4 |
1.284300E-02 |
| Grade 3-vs-Grade 4 |
2.671200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.411800E-04 |
| Normal-vs-ccB subtype |
2.185000E-03 |
| ccA subtype-vs-ccB subtype |
8.885600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.977800E-04 |
| Normal-vs-N1 |
4.044400E-04 |
| N0-vs-N1 |
1.685640E-01 |
|
|
